Idarubicin and anaemia Patient Reports February 12, 2012

Idarubicin Side Effects Report #5344518-6
Idarubicin side effect was reported by a Consumer or non-health professional from KOREA, REPUBLIC OF on May 23, 2007. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia, ovarian epithelial cancer and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, asthenia, renal failure acute, thrombocytopenia. Idarubicin dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, PACLITAXEL, TOPOTECAN, ENOCITABINE. Patient was hospitalized. Patient died.

Idarubicin Side Effects Report #5071665-9
Idarubicin side effect was reported by a Health Professional from AUSTRALIA on July 19, 2006. Male patient, 27 years of age, was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: anaemia, enterocolitis, eye disorder, febrile neutropenia, ileus, klebsiella sepsis, liver function test abnormal, lung consolidation. Idarubicin dosage: (16 MG, DAILY), INTRAVENOUS. During the same period patient was treated with CYTARABINE, ETOPOSIDE. Patient recovered.

Idarubicin Side Effects Report #5282211-9
Idarubicin side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 19, 2007. Male patient, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia. Idarubicin dosage: unknown. During the same period patient was treated with ETOPOSIDE, CYTARABINE, PEGFILGRASTIM, ACYCLOVIR, FLUCONAZOLE, PANTOPRAZOLE, NYSTATIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Idarubicin Side Effects Report #5288994-6
Idarubicin side effect was reported by a Consumer or non-health professional from AUSTRALIA on Mar 28, 2007. Male patient, weighting 213.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: anaemia, febrile neutropenia. Idarubicin dosage: unknown. During the same period patient was treated with CYTARABINE, ETOPOSIDE, PEGFILGRASTIM, ACYCLOVIR, FLUCONAZOLE, PANTOPRAZOLE, NYSTATIN, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.


Idarubicin Side Effects Report #6135414-5
Idarubicin side effect was reported by a Health Professional from GERMANY on Mar 16, 2009. Female patient was diagnosed with acute myeloid leukaemia and was treated with Idarubicin. After drug was administered, patient experienced the following side effects: anaemia, cardiomyopathy , cerebral ventricle dilatation, foetal growth retardation. Idarubicin dosage: 10 MG/M2, ON DAYS 2-4. During the same period patient was treated with MITOXANTRONE HYDROCHLORIDE, CYTARABINE, FLUDARABINE, GEMTUZUMAB OZOGAMICIN. Patient recovered.